Release Date: 22/08/16 15:34 Summary: Suspension from Official Quotation (close 24/08/16)-GMM.AX Price Sensitive: Yes Download Document 246.16KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%